United States · FDA National Drug Code directory
Docetaxel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47335-939_9a0d7b91-4324-4e19-9cd8-eb19266e771a
- Product NDC
- 47335-939
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Docetaxel
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20201126
- Source listing expiry
- 20261231
Source-listed ingredients
- DOCETAXEL ANHYDROUS — 160 mg/8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (47335-939-40) / 8 mL in 1 VIAL, GLASS · 47335-939-40
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →